MAPK3 and gastric cancer: Proteomics analysis and further functional studies demonstrated that compound 9 binds to CypA and downregulates the CD147-mediated MAPK signaling pathway, including JNK and ERK1/2, by inhibiting CypA and CD147 expression in gastric cancer cells [13].